dc.creatorLima, Isabella
dc.creatorMelo, Ailton de Souza
dc.creatorBrandi, Ivar Viana
dc.creatorCosta, Olívia Lúcia Nunes
dc.creatorSantiago, Mittermayer Barreto
dc.creatorLima, Isabella
dc.creatorMelo, Ailton de Souza
dc.creatorBrandi, Ivar Viana
dc.creatorCosta, Olívia Lúcia Nunes
dc.creatorSantiago, Mittermayer Barreto
dc.date.accessioned2022-10-07T19:07:55Z
dc.date.available2022-10-07T19:07:55Z
dc.date.issued2007
dc.identifier1076-1608
dc.identifierhttp://repositorio.ufba.br/ri/handle/ri/15976
dc.identifierv. 13, n. 2
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4012971
dc.description.abstractA multiple sclerosis-like syndrome, also called lupoid sclerosis for having some lupus characteristics, has been described in a few reports. Recently, antiphospholipid antibodies have been demonstrated in patients with this syndrome, suggesting that they can participate in the etiopathogenic process, which can have therapeutic implications. We report the case of a patient previously diagnosed with multiple sclerosis who later presented with ANA positivity and antiphospholipid antibodies, livedo reticularis, and deep venous thrombosis, leading her to be characterized as having lupoid sclerosis. The patient was anticoagulated. Antiphospholipid antibodies may be involved in the pathogenesis of lupoid sclerosis.
dc.languageen
dc.rightsAcesso Aberto
dc.sourcehttp://dx.doi.org/10.1097/01.rhu.0000260637.95695.40
dc.subjectMultiple sclerosis
dc.subjectLupus
dc.subjectLupoid sclerosis
dc.subjectAntiphospholipid syndrome
dc.titleLupoid sclerosis: what is the role of antiphospholipid antibodies?
dc.typeArtigo de Periódico


Este ítem pertenece a la siguiente institución